Resolved

WIXELA INHUB

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of WIXELA INHUB in Canada?

Not currently. The most recent shortage report for WIXELA INHUB 500MCG 50MCG is marked resolved (last updated August 25, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength500MCG 50MCG

Last updated2026-08-25

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02495619

Strength

500MCG 50MCG

Dosage Form

POWDER

Route

INHALATION

Active Ingredient

FLUTICASONE PROPIONATE SALMETEROL

Tier

Unrated

Last Updated

2026-08-25

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

40MG · DIN 02257963

10MG · DIN 02257955

DIN 02388138

DIN 02388146